Vancomycin-resistant enterococci cost-effectiveness of therapy

Revision as of 19:06, 18 September 2017 by WikiBot (talk | contribs) (Changes made per Mahshid's request)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Vancomycin-resistant enterococci Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Vancomycin-Resistant Enterococci from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Vancomycin-resistant enterococci cost-effectiveness of therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Vancomycin-resistant enterococci cost-effectiveness of therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA onVancomycin-resistant enterococci cost-effectiveness of therapy

CDC on Vancomycin-resistant enterococci cost-effectiveness of therapy

enterococci cost-effectiveness of therapy in the news

on Vancomycin-resistant enterococci cost-effectiveness of therapy

Directions to Hospitals Treating Vancomycin-resistant enterococci

Risk calculators and risk factors for Vancomycin-resistant enterococci cost-effectiveness of therapy

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

References


Template:WH Template:WS